Literature DB >> 31907538

Iron Overload Associated Endocrine Dysfunction Leading to Lower Bone Mineral Density in Thalassemia Major.

Wen-Ping Yang1,2, Hsiu-Hao Chang3, Hung-Yuan Li1, Ying-Chuen Lai1, Tse-Ying Huang1, Keh-Sung Tsai1,4, Kai-Hsin Lin3, Dong-Tsamn Lin3, Shiann-Tarng Jou3, Meng-Yao Lu3, Yung-Li Yang3,5,6, Shu-Wei Chou3, Shyang-Rong Shih1,7,8.   

Abstract

CONTEXT: Patients with thalassemia major (TM) have a lower bone mineral density (BMD) and higher risk of fracture than the general population. The possible mechanisms include anemia, iron overload, malnutrition, and hormonal deficiency, but these have not been thoroughly investigated.
OBJECTIVE: To identify major mineral and hormonal factors related to BMD in adult TM patients to provide human evidence for the proposed mechanisms.
DESIGN: Retrospective study.
SETTING: Referral center. PATIENTS: Twenty-nine patients with β-TM, aged 23 to 44 years who were followed-up during 2017 to 2018 were enrolled. OUTCOME MEASUREMENTS: Endocrine profiles, including thyroid, parathyroid, and pituitary function, glucose, vitamin D, calcium, phosphate, and fibroblast growth factor 23 (FGF23) were obtained. The relationships among the above parameters, body height, fractures, and BMD were analyzed.
RESULTS: Abnormal BMD was observed in 42.9% of women and 23.1% of men. The mean final heights of women and men were 3.7 cm and 7.3 cm lower than the mean expected values, respectively. Fracture history was recorded in 26.7% of women and 35.7% of men. BMD was negatively correlated with parathyroid hormone, FGF23, thyrotropin, and glycated hemoglobin (HbA1c) levels, and positively correlated with testosterone, IGF-1, and corticotropin levels (all P < .05). Moreover, hypothyroidism was associated with lower BMD in both the lumbar spine (P = .024) and the femoral neck (P = .004). Patients with hypothyroidism had a higher percentage of abnormal BMD (P = .016).
CONCLUSION: Hypothyroidism, higher HbA1c, and lower adrenocorticotropin were predictors of abnormal BMD in patients with β-TM. Whether the correction of these factors improves BMD warrants further research. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  bone mineral density; corticotropin; hemoglobin A1c; pituitary; thalassemia major; thyroid

Year:  2020        PMID: 31907538     DOI: 10.1210/clinem/dgz309

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  The HIF-PHI BAY 85-3934 (Molidustat) Improves Anemia and Is Associated With Reduced Levels of Circulating FGF23 in a CKD Mouse Model.

Authors:  Megan L Noonan; Pu Ni; Rafiou Agoro; Spencer A Sacks; Elizabeth A Swallow; Jonathan A Wheeler; Erica L Clinkenbeard; Maegan L Capitano; Matthew Prideaux; Gerald J Atkins; William R Thompson; Matthew R Allen; Hal E Broxmeyer; Kenneth E White
Journal:  J Bone Miner Res       Date:  2021-03-10       Impact factor: 6.741

Review 2.  Iron Therapy in Chronic Kidney Disease: Days of Future Past.

Authors:  Kuo-Hua Lee; Yang Ho; Der-Cherng Tarng
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

3.  Fibroblast growth factor 21 (FGF21) is a sensitive marker of osteoporosis in haemodialysis patients: a cross-sectional observational study.

Authors:  Lili Zhu; Min Li; Qianqian Zha; Min Yang; Jirong Yu; Mingming Pan; Qing Yin; Liqiong Jiang; Meixia Xia; Bi-Cheng Liu; Bin Wang
Journal:  BMC Nephrol       Date:  2021-05-19       Impact factor: 2.388

4.  Mild-intensity physical activity prevents cardiac and osseous iron deposition without affecting bone mechanical property or porosity in thalassemic mice.

Authors:  Narattaphol Charoenphandhu; Supagarn Sooksawanwit; Ratchaneevan Aeimlapa; Natchayaporn Thonapan; Pornpailin Upanan; Punyanuch Adulyaritthikul; Saowalak Krungchanuchat; Nattapon Panupinthu; Jarinthorn Teerapornpuntakit; Catleya Rojviriya; Kornkamon Lertsuwan; Saovaros Svasti; Kannikar Wongdee
Journal:  Sci Rep       Date:  2022-04-08       Impact factor: 4.379

Review 5.  New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement.

Authors:  Mara Carsote; Cristina Vasiliu; Alexandra Ioana Trandafir; Simona Elena Albu; Mihai-Cristian Dumitrascu; Adelina Popa; Claudia Mehedintu; Razvan-Cosmin Petca; Aida Petca; Florica Sandru
Journal:  Diagnostics (Basel)       Date:  2022-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.